Net assets
Presentation of net assets
Total assets increased to €3403.4m as of 30 September 2025 (30 September 2024: €3,393.2m).
Non-current assets decreased from €2,180.7m as of 30 September 2024 to €2,123.1m as of 30 September 2025. The main reasons for the reduction were amortization of intangible assets and depreciation of property, plant and equipment as well as negative currency effects. Investments in property, plant, and equipment for the expansion of production capacities, capitalization of development costs, and changes in investments accounted for using the equity method had an offsetting effect.
Current assets amounted to €1,280.3m (30 September 2024: €1,212.5m). Despite a reduction in inventories on the reporting date, an increase in trade receivables from related parties and treasury receivables on the reporting date due to an increase in the operating result led to an increase in assets.
The equity recognized in the Carl Zeiss Meditec Group’s statement of financial position amounted to €2,127.7m as of 30 September 2025 (30 September 2024: €2,056.5m). The equity ratio was 62.5% (30 September 2024: 60.6%), and thus rose slightly, due to the operating result and lower borrowed capital.
Non-current liabilities decreased to €731.9m as of 30 September 2025 (30 September 2024: €767.9m), due in particular to the repayment of leasing liabilities.
As of 30 September 2025, current liabilities decreased to €543.8m (30 September 2024: €568.8m). This was mainly due to the significant decrease in treasury payables. This was offset by the increase in trade payables to related parties.
Structure of statement of financial position – Assets
in €m
Structure of statement of financial position – Equity and liabilities
in €m
|
|
|
|
30 Sep 2025 |
|
30 Sep 2024 |
|
Change |
|---|---|---|---|---|---|---|---|---|
Key ratio |
|
Definition |
|
in % |
|
in % |
|
% pts |
Equity ratio |
|
Equity (including non-controlling interests) |
|
62.5 |
|
60.6 |
|
+1.9 |
|
Total assets |
|
|
|
||||
Inventories in % of rolling 12-month revenue |
|
Inventories (net) |
|
22.3 |
|
26.0 |
|
-3.6 |
|
Rolling revenue |
|
|
|
||||
Receivables in % of rolling 12-month revenue |
|
Trade receivables at the end of the reporting period (including non-current receivables) |
|
23.8 |
|
21.6 |
|
+2.2 |
|
Rolling revenue |
|
|
|